SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-040076
Filing Date
2024-02-20
Accepted
2024-02-20 16:55:59
Documents
1
Group Members
BALDERTON CAPITAL GENERAL PARTNER VI, S.A.R.L.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d765279dsc13ga.htm SC 13G/A 45293
  Complete submission text file 0001193125-24-040076.txt   46902
Mailing Address 2-8 AVENUE CHARLES DE GAULLE LUXEMBOURG N4 L-1653
Business Address 2-8 AVENUE CHARLES DE GAULLE LUXEMBOURG N4 L-1653 352 24 870 210
Balderton Capital VI, S.L.P. (Filed by) CIK: 0001702178 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address LA PIECE, CH-1180 ROLLE V8 00000
Business Address LA PIECE, CH-1180 ROLLE V8 00000 41 21 694 10 60
SOPHiA GENETICS SA (Subject) CIK: 0001840706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93219 | Film No.: 24654471
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)